Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
Notes payable	$ 773,279	$ 773,279
Unaudited
Cash and cash equivalents	41,178	22,132
Due from related party	90,387	295,912
Promissory note	2,000	3,000
Total Current Assets	133,565	321,044
Patents	7,000	7,000
Total Assets	140,565	328,044
Accounts payable	797,908	797,908
Accrued expenses	2,132,019	1,986,726
Derivative liability	21,160	429,296
Notes payable	773,279	773,279
Notes payables	325,000	225,000
Convertible notes payable, net	13,296	117,534
Total Current Liabilities	4,062,662	4,329,743
Common stock (Par value $0.001 authorized 100,000,000 shares, issued and outstanding 96,851,941 and 93,209,823 at September 30, 2014 and December 31, 2013, respectively)	96,852	93,210
Additional paid in capital	31,370,075	30,248,060
Common stock-warrants	97,869	97,869
Deferred compensation		(12,609)
Accumulated deficit	(35,486,893)	(34,428,228)
Total stockholders deficit	(3,922,097)	(4,001,698)
Total Liabilities and stockholders deficit	$ 140,565	$ 328,044